Form 8-K - Current report:
SEC Accession No. 0001437749-23-006262
Filing Date
2023-03-13
Accepted
2023-03-13 06:47:22
Documents
13
Period of Report
2023-03-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20230310_8k.htm   iXBRL 8-K 24364
  Complete submission text file 0001437749-23-006262.txt   155812

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wint-20230313.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20230313_def.xml EX-101.DEF 11533
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20230313_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20230313_pre.xml EX-101.PRE 11689
7 EXTRACTED XBRL INSTANCE DOCUMENT wint20230310_8k_htm.xml XML 2565
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 23725639
SIC: 2836 Biological Products, (No Diagnostic Substances)